0001179110-18-011143.txt : 20180906 0001179110-18-011143.hdr.sgml : 20180906 20180906160221 ACCESSION NUMBER: 0001179110-18-011143 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180904 FILED AS OF DATE: 20180906 DATE AS OF CHANGE: 20180906 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bosley Katrine CENTRAL INDEX KEY: 0001592469 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37687 FILM NUMBER: 181057572 MAIL ADDRESS: STREET 1: C/O EDITAS MEDICINE STREET 2: 11 HURLEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02141 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Editas Medicine, Inc. CENTRAL INDEX KEY: 0001650664 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 464097528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-401-9000 MAIL ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 4 1 edgar.xml FORM 4 - X0306 4 2018-09-04 0 0001650664 Editas Medicine, Inc. EDIT 0001592469 Bosley Katrine C/O EDITAS MEDICINE, INC. 11 HURLEY ST. CAMBRIDGE MA 02141 1 1 0 0 President and CEO Common Stock 2018-09-04 4 S 0 10787 32.27 D 1254179 D Common Stock 2018-09-04 4 S 0 1213 33.07 D 1252966 D The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2017, as amended. This transaction was executed in multiple trades at prices ranging from $31.79 to $32.78. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $32.79 to $33.25. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Katrine Bosley 2018-09-06